Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
Clinical trial NCT00038649 · TERMINATED
Trial details
- NCT number
- NCT00038649
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-06-01
- Primary completion
- 2013-11-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.